Oral microencapsulated diindolylmethane
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral microencapsulated diindolylmethane, covering 2014-02-12 to 2014-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery [Phase 2]